Browsing by Autor "Janinne Ortega-Montiel"

Now showing 1 - 5 of 5

Trends of antihypertensive, antidiabetic, and non-steroidal anti-inflammatory drugs use among the Health Workers Cohort Study, Mexico 2004 to 2018
(2022) Janinne Ortega-Montiel; Alejandra Montoya; René Soria-Saucedo; Katia Gallegos-Carrillo; Paula Ramírez‐Palacios; Jorge Salmerón; Eduardo Salazar-Martı́nez
<title>Abstract</title> <italic>Background</italic> Hypertension and Type 2 Diabetes are the most prevalent non-communicable diseases in Mexico and worldwide. The principal management therapy for these diseases is daily oral medication according to international practice management guidelines. We aim to describe the trends of the utilization of antihypertensive, antidiabetic, and non-steroidal anti-inflammatories drugs among Mexican adult population from 2004-2018 through three waves. <italic>Methods</italic> We conducted a longitudinal analysis using data from the Health Workers Cohort Study (HWCS), males and females, aged <underline>></underline> 18 years. The prevalence of chronic diseases and utilization for every kind of antihypertensive, antidiabetic, and NSAIDs (measured by self-reported utilization) available, were calculated in each of the three study waves, and trends were analyzed using Fisher’s exact test. <italic>Results</italic> Hypertension prevalence increased from 19.8 to 30.3%, same as Diabetes prevalence from 7.0 to 12.8% through fourteen years of follow up. The proportion of patients using beta-blockers and ARB II increased, same as the self-reported of combined therapy. A complete change in initiating treatment for T2D was observed since the second wave with metformin prevalence utilization of 83.9%. The utilization of common NSAIDs, mainly for muscular pain, remained around 13 to 16%. <italic>Conclusions</italic> Our findings showed markedly changing utilization drugs prevalence for hypertension and type 2 diabetes between 2004 and 2018, and consistent utilization of NSAIDs (acetaminophen mainly) in adult Mexican population.
Trends of antihypertensive, antidiabetic, and non-steroidal anti-inflammatory drugs use among the Health Workers Cohort Study, Mexico 2004 to 2018.
(2023) Janinne Ortega-Montiel; Alejandra Montoya; René Soria-Saucedo; Katia Gallegos-Carrillo; Paula Ramírez‐Palacios; Jorge Salmerón; Eduardo Salazar-Martı́nez
<title>Abstract</title> <italic>Background</italic> Hypertension and type 2 diabetes (T2D) are the most prevalent non-communicable diseases in Mexico and worldwide. According to international practice management guidelines, the principal chronic management therapy is daily oral medication. <italic>Aim</italic> We aim to describe the trends of antihypertensive, antidiabetic, and non-steroidal anti-inflammatory (NSAID) drugs use among the Mexican adult population from 2004-2018. <italic>Methods</italic> We analyzed data from the Health Workers Cohort Study (HWCS) for males and females aged <underline>></underline> 18 years. We calculated the prevalence of chronic diseases and utilization for every kind of antihypertensive, antidiabetic, and NSAIDs (measured by self-reported utilization) at baseline and two follow up (2004, 2010, and 2017). Trends were analyzed using Fisher’s exact test. <italic>Results</italic> Hypertension prevalence increased from 19.8 to 30.3%, higher than T2D prevalence from 7.0 to 12.8% through fourteen years of follow-up. Like the self-reported dual therapy, the proportion of patients using beta-blockers and angiotensin II receptor blockers increased. Regarding T2D, the prevalence of metformin utilization increased to 83.9%. The utilization of common NSAIDs, mainly for muscular pain, remained around 13 to 16%. <italic>Conclusions</italic> Our findings showed a changing prevalence of drug utilization for hypertension and T2D between 2004 and 2018 and consistent use of NSAIDs in the adult Mexican population.
Trends of antihypertensive, antidiabetic, and non-steroidal anti-inflammatory drugs use among the Health Workers Cohort Study, Mexico 2004 to 2018.
(2022) Janinne Ortega-Montiel; Alejandra Montoya; René Soria-Saucedo; Katia Gallegos-Carrillo; Paula Ramírez‐Palacios; Jorge Salmerón; Eduardo Salazar-Martı́nez
<title>Abstract</title> <italic>Purpose</italic> Hypertension and Type 2 Diabetes (T2D) are the most prevalent non-communicable diseases in Mexico and worldwide. The principal chronic management therapy is daily oral medication according to international practice management guidelines. We aim to describe the trends of the utilization of antihypertensive, antidiabetic, and non-steroidal anti-inflammatories drugs (NSAID) among Mexican adult population from 2004-2018 through three waves. <italic>Methods</italic> We conducted a longitudinal analysis using data from the Health Workers Cohort Study (HWCS), males and females, aged <underline>></underline> 18 years. The prevalence of chronic diseases and utilization for every kind of antihypertensive, antidiabetic, and NSAIDs (measured by self-reported utilization) were calculated in each of the three study waves, and trends were analyzed using Fisher’s exact test. <italic>Results</italic> Hypertension prevalence increased from 19.8 to 30.3%, same as Diabetes prevalence from 7.0 to 12.8% through fourteen years of follow-up. The proportion of patients using beta-blockers and angiotensin receptor blocker II increased, same as the self-reported dual therapy. Regarding T2D, the prevalence of metformin utilization rose to 83.9%. The utilization of common NSAIDs, mainly for muscular pain, remained around 13 to 16%. <italic>Conclusions</italic> Our findings showed markedly changing utilization drugs prevalence for hypertension and T2D between 2004 and 2018, and consistent utilization of NSAIDs (acetaminophen mainly) in the adult Mexican population.
Trends of antihypertensive, antidiabetic, and non-steroidal anti-inflammatory drugs use among the Health Workers Cohort Study, Mexico 2004 to 2018.
(2023) Janinne Ortega-Montiel; Alejandra Montoya; René Soria-Saucedo; Katia Gallegos-Carrillo; Paula Ramírez‐Palacios; Jorge Salmerón; Eduardo Salazar-Martı́nez
<title>Abstract</title> <italic>Purpose</italic> Hypertension and Type 2 Diabetes (T2D) are the most prevalent non-communicable diseases in Mexico and worldwide. According to international practice management guidelines, the principal chronic management therapy is a daily oral medication. We aim to describe the trends of antihypertensive, antidiabetic, and non-steroidal anti-inflammatory (NSAID) drugs use among the Mexican adult population from 2004-2018. <italic>Methods</italic> We analyzed data from the Health Workers Cohort Study (HWCS) for males and females aged <underline>></underline> 18 years. The prevalence of chronic diseases and utilization for every kind of antihypertensive, antidiabetic, and NSAIDs (measured by self-reported utilization) were calculated at baseline and two follow up (2004-2010-2017). Trends were analyzed using Fisher’s exact test. <italic>Results</italic> Hypertension prevalence increased from 19.8 to 30.3%, higher than T2D prevalence from 7.0 to 12.8% through fourteen years of follow-up. The proportion of patients using beta-blockers and angiotensin II receptor blockers increased, like the self-reported dual therapy. Regarding T2D, the prevalence of metformin utilization increased to 83.9%. The utilization of common NSAIDs, mainly for muscular pain, remained around 13 to 16%. <italic>Conclusions</italic> Our findings showed a clearly changing prevalence of drug utilization for hypertension and T2D between 2004 and 2018 and consistent use of NSAIDs (acetaminophen mainly) in the adult Mexican population.
Trends of Antihypertensive, Antidiabetic, and Nonsteroidal Anti-Inflammatory Drugs Use among the Health Workers Cohort Study, Mexico 2004 to 2018
(Hindawi Publishing Corporation, 2023) Janinne Ortega-Montiel; Alejandra Montoya; René Soria-Saucedo; Katia Gallegos-Carrillo; Paula Ramírez‐Palacios; Jorge Salmerón; Eduardo Salazar-Martínez
Our findings showed a changing prevalence of drug utilization for hypertension and T2D between 2004 and 2018 and consistent use of NSAIDs in the adult Mexican population.